The NHS in the UK is planning to sell anonymized patient data to raise funds, spark research and improve patient outcomes – a controversial move set to benefit companies like Palantir Technologies. Critics are concerned about compromised patient confidentiality and security risks. NHS has an opt-out page for those not wishing to share data and has pledged not to sell data to insurance or marketing firms.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
